top of page
Browse by category
Search


Increase in number of cases of acute and chronic pancreatitis linked to GLP-1 medicines
Data from the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has revealed that since...


Head-to-head study shows five times more weight loss with surgery than GLP-1s after two years
Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor...


Psychiatric disorders less likely after BMS than treatment with GLP-1s
People who have bariatric and metabolic surgery (BMS) are significantly less likely to develop psychiatric disorders compared to those...


GLP-1 prescriptions increase by 364% whilst BMS declines by 42%
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled,...


GLP-1 drugs benefit children who are living with severe obesity
Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs...


GLP-1s cut alcohol intake by almost two-thirds
Individuals who take liraglutide or semaglutide for weight loss reduced their alcohol consumption by almost two-thirds in four months,...


GLP-s are safe and effective for treating obesity in adults with mental illness
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with...


Women more likely to be aware of and have good understanding of obesity drugs
Women are much more aware of and knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and...


GLP-1ras show anti-cancer benefits beyond weight loss
First generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss. Indeed,...


GLP-1s post-bariatric surgery offer additional cardiovascular benefits
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may help to reduce the risk of heart attacks, strokes, and other major adverse...
Browse by tag






bottom of page